MatTek Life Sciences
Alex Armento currently serves as the Chief Executive Officer of Visikol since September 2023. Prior to this role, Alex Armento held multiple positions at MatTek Corporation, starting as a Research Associate in July 2008 and advancing to Sales and Marketing Manager, Director of Business Development, and ultimately President and Chief Executive Officer. Alex Armento's educational background includes a Master of Arts in Biomolecular Sciences from Central Connecticut State University, obtained between 2007 and 2008, as well as a Bachelor of Science in the same field from the same institution, completed in 2006.
MatTek Life Sciences
MatTek is a provider of advanced in-vitro technology for clinical and pre-clinical studies offering in-vitro human tissue model innovation, cell isolation, and cell culture. The company is the world leader in the production of innovative 3D reconstructed human-derived tissue models used for product development and regulatory testing applications.MatTek has developed the largest portfolio of proprietary 3D human tissue and disease models in the world with a prominent customer base.